The Global Synthetic Biology Market to Hit $59.91 Billion by 2029, More than $44 Billion Opportunities in the Next 6 Years – Arizton

“Synthetic Biology Market Research Report by Arizton”
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2024–2029.

    

According to Arizton’s latest research report, the global synthetic biology market is growing at a CAGR of 25.68% during 2023-2029.

 

Looking for More Information? Click: https://www.arizton.com/market-reports/synthetic-biology-market

 

Report Scope:     

Market Size (2029): $59.91 Billion         

Market Size (2023): $15.20 Billion         

CAGR (2023-2029): 25.68%          

Historic Year:  2020-2022             

Base Year: 2023             

Forecast Year: 2024-2029             

Market Segmentation: Tool, Technology, Application, End-User, and Geography

Geographical Analysis: North America, Europe, APAC, Latin America, and Middle East & Africa     

     

Book the Free Sample Now: https://www.arizton.com/market-reports/synthetic-biology-market

 

The global synthetic biology market is highly competitive, with major players like Agilent Technologies, Codexis, Eurofins Scientific, Illumina, Novozymes, and Thermo Fisher Scientific commanding significant market shares. These leading companies face intense competition from both emerging and established players, driving ongoing technological innovation and product development across sectors such as healthcare, industrial applications, food and beverages, agriculture, and environmental solutions.

To sustain their market position and expand their reach, key players are focusing on organic growth strategies. This includes launching new products, enhancing existing ones, and securing patents for innovative technologies. These strategies are bolstered by substantial investments in research and development (R&D), which lead to valuable collaborations and acquisitions that enhance their product offerings and market expertise.

Despite the strong presence of major companies, the synthetic biology market presents substantial growth opportunities for smaller and emerging players. These companies are actively developing advanced synthetic biology tools and technologies, contributing to the market’s dynamic nature and fostering new opportunities for innovation and market entry. The increasing global demand for advanced healthcare solutions and other applications particularly drives this growth.

 

Strategic Initiatives and New Collaborations in the Synthetic Biology Market

Novozymes and Codexis are actively pursuing strategic initiatives to bolster their market presence, including the launch of new products and fostering collaborative efforts. Similarly, Agilent Technologies and Eurofins Scientific are key players focusing on introducing new products in targeted regions to increase their global market share.

In 2023, Sumitomo Chemical and Ginkgo Bioworks launched a new initiative to utilize synthetic biology to produce functional chemicals, marking their third collaborative project. Since 2021, the two companies have worked together on biomanufacturing solutions for personal care, cosmetics, agriculture, and pharmaceuticals. Their latest project is aimed at enabling large-scale production of functional chemicals through fermentation.

 

Key Vendors

  • Agilent Technologies
  • Codexis
  • Eurofins Scientific
  • Illumina
  • Novozymes
  • Thermo Fisher Scientific
  • Amyris
  • ATUM
  • Bio-Rad Laboratories
  • Creative Biogene
  • Creative Enzymes
  • Cyrus Biotechnology
  • Editas Medicine
  • Genomatica
  • Genscript
  • Ginkgo Bioworks
  • Integrated DNA Technologies
  • LGC Biosearch Technologies
  • New England Biolabs
  • OriGene Technologies
  • Precigen
  • Sentebiolab
  • SynbiCITE
  • Synthego
  • Tessera Therapeutics
  • Viridos
  • Asimov
  • Twist Bioscience
  • Mammoth Biosciences
  • ElevateBio
  • Dupont
  • DSM
  • Bota Biosciences
  • Kiverdi
  • Merck KGaA
  • Synlogic
  • Huee
  • Upside Foods

 

Pharma and Biotech Companies Lead Growth in Global Synthetic Biology Market

Pharma and biotech companies are experiencing the highest growth in the global synthetic biology market. These industries have been instrumental in the early achievements of synthetic biology, primarily due to its close relationship with small-molecule drug production. Many of these drugs are derived from natural sources, making it relatively easy to adapt microbial production systems. Additionally, the modular nature of many biosynthetic pathways, especially those used in producing bioactive natural products like antibiotics, aligns well with synthetic biology’s engineering techniques. These pathways evolved for rapid diversification and cross-species compatibility and often feature large modular assembly lines, providing ideal opportunities for applying synthetic biology approaches.

 

Segmentation & Forecast

 

Tool

  • Oligonucleotides and Synthetic DNA
  • Enzymes
  • Cloning Technology Kits
  • Xeno-Nucleic Acids
  • Chassis Organisms

 

Technology

  • Enabling Technology
  • Enabled Technology

 

Application

  • Healthcare Application
  • Industrial Application
  • Food & Agriculture Application
  • Environmental Application

 

End-User

  • Academic/Research Institutes & Laboratories
  • Pharma & Biotech Companies
  • Others

 

North America Leads the Global Synthetic Biology Market with Strong R&D and Regulatory Support

North America dominates the global synthetic biology market, holding the largest share. The region features a vibrant synthetic biology sector, with over 530 regenerative medicine companies specializing in cell and gene therapy and stem cell-based treatments. These companies are at the forefront of research and development, leveraging synthetic biology to advance medical treatments. The US excels in conducting clinical trials of cell and gene therapy, with a rising number of patients opting for these innovative therapies. Frequent regulatory approvals in North America further bolster the region’s leadership in synthetic biology.

 

Geography

 

North America

  • The U.S.
  • Canada

 

Europe

  • Germany
  • The U.K.
  • France
  • Italy
  • Spain

 

APAC

  • Japan
  • China
  • India
  • Australia
  • South Korea

 

Latin America

  • Brazil
  • Mexico
  • Argentina

 

Middle East & Africa

  • Turkey
  • South Africa
  • Saudi Arabia

 

In a nutshell, the Arizton Advisory & Intelligence market research report provides valuable market insights for industry stakeholders, investors, researchers, consultants, and business strategists aiming to gain a thorough understanding of the synthetic biology market. Request for Free Sample to get a glance at the report now: https://www.arizton.com/market-reports/synthetic-biology-market

 

What Key Findings Will Our Research Analysis Reveal?   

What are the key drivers of the global synthetic biology market?

How big is the global synthetic biology market?

Which region dominates the global synthetic biology market?

What is the growth rate of the global synthetic biology market?

Who are the major players in the global synthetic biology market?

   

Looking for Customization According to Your Business Requirement? https://www.arizton.com/customize-report/4490

 

Other Related Reports that Might be of Your Business Requirement   

Europe Cell And Gene Therapy Market – Focused Insights 2024-2029

The Europe cell and gene therapy market was valued at USD 2.26 billion in 2023 and is expected to reach USD 14.45 billion by 2029. Explore! https://www.arizton.com/market-reports/europe-cell-gene-therapy-market-size-analysis

Cell Counting Devices Market – Global Outlook & Forecast 2024-2029

The global cell counting devices market was valued at USD 12.39 billion in 2023 and is expected to reach USD 18.64 billion by 2029. Learn more about the market now: https://www.arizton.com/market-reports/cell-counting-devices-market

 

Why Arizton?                                              

100% Customer Satisfaction                                              

24×7 availability – we are always there when you need us                                              

200+ Fortune 500 Companies trust Arizton’s report                                              

80% of our reports are exclusive and first in the industry                                              

100% more data and analysis                                              

1500+ reports published till date                            

                 

Post-Purchase Benefit                                          

  • 1hr of free analyst discussion                                          
  • 10% off on customization                       

                

About Us:                                                                                   

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                                                 

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                                                  

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                                                        

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1-312-235-2040/+1 302 469 0707                                      
Country: United States
Website: https://www.arizton.com/market-reports/synthetic-biology-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Global Synthetic Biology Market to Hit $59.91 Billion by 2029, More than $44 Billion Opportunities in the Next 6 Years – Arizton